Literature DB >> 10997273

Development of a destabilized firefly luciferase enzyme for measurement of gene expression.

G M Leclerc1, F R Boockfor, W J Faught, L S Frawley.   

Abstract

Firefly luciferase is used widely as a reporter enzyme for studies of gene regulation and expression. The recent development of new technologies that combine luciferase reporter technology and digital imaging microscopy has enabled multiple measurements of gene expression in the same living cell. Although this approach has already provided new insights about expression dynamics, its future utility is limited by the three- to four-hour half-life of firefly luciferase in mammalian cells. Because of this, rapid increases or decreases in gene expression may not be detected, owing to the accumulation of residual luciferase. Accordingly, the goal of the present study was to develop a luciferase reporter with a reduced functional half-life. This was accomplished by adding a synthetic fragment to the firefly luciferase-coding sequence that encoded the proteolytic "PEST" signal from mouse ornithine decarboxylase. When placed under the control of estrogen response elements and expressed in human breast cancer T-47D cells, the modified luciferase protein (LUCODC-DA) displayed a functional half-life of 0.84 h compared to 3.68 h for the wild-type enzyme. As anticipated, the overall rate of photonic emissions in cells expressing the destabilized luciferase was about sevenfold lower than that of their wild-type counterparts, presumably because of the reduction of steady-state luciferase accumulation. Even so, the photonic activity derived from LUCODC-DA was still sufficient to enable real-time measurements of gene expression in single living cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10997273     DOI: 10.2144/00293rr02

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  45 in total

1.  Core promoter elements and TAFs contribute to the diversity of transcriptional activation in vertebrates.

Authors:  Zheng Chen; James L Manley
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

Review 2.  Engineered antibody therapies to counteract mutant huntingtin and related toxic intracellular proteins.

Authors:  David C Butler; Julie A McLear; Anne Messer
Journal:  Prog Neurobiol       Date:  2011-11-18       Impact factor: 11.685

Review 3.  Applications of bioluminescence imaging to antiviral research and therapy: multiple luciferase enzymes and quantitation.

Authors:  Kathryn E Luker; Gary D Luker
Journal:  Antiviral Res       Date:  2008-03-05       Impact factor: 5.970

4.  Basal levels of eIF2alpha phosphorylation determine cellular antioxidant status by regulating ATF4 and xCT expression.

Authors:  Jan Lewerenz; Pamela Maher
Journal:  J Biol Chem       Date:  2008-11-18       Impact factor: 5.157

5.  A gantry-based tri-modality system for bioluminescence tomography.

Authors:  Han Yan; Yuting Lin; William C Barber; Mehmet Burcin Unlu; Gultekin Gulsen
Journal:  Rev Sci Instrum       Date:  2012-04       Impact factor: 1.523

6.  Luciferase reporter assay in Drosophila and mammalian tissue culture cells.

Authors:  Chi Yun; Ramanuj DasGupta
Journal:  Curr Protoc Chem Biol       Date:  2014-03-14

7.  An enhanced chimeric firefly luciferase-inspired enzyme for ATP detection and bioluminescence reporter and imaging applications.

Authors:  Bruce R Branchini; Tara L Southworth; Danielle M Fontaine; Dawn Kohrt; Munya Talukder; Elisa Michelini; Luca Cevenini; Aldo Roda; Martha J Grossel
Journal:  Anal Biochem       Date:  2015-06-04       Impact factor: 3.365

8.  Multiplexing bioluminescent and fluorescent reporters to monitor live cells.

Authors:  Michael Haugwitz; Omar Nourzaie; Tatiana Garachtchenko; Lanrong Hu; Suvarna Gandlur; Cathy Olsen; Andrew Farmer; Grigoriy Chaga; Hiroaki Sagawa
Journal:  Curr Chem Genomics       Date:  2008-02-25

9.  Improved Tet-responsive promoters with minimized background expression.

Authors:  Rainer Loew; Niels Heinz; Mathias Hampf; Hermann Bujard; Manfred Gossen
Journal:  BMC Biotechnol       Date:  2010-11-24       Impact factor: 2.563

10.  An Ebola Virus-Like Particle-Based Reporter System Enables Evaluation of Antiviral Drugs In Vivo under Non-Biosafety Level 4 Conditions.

Authors:  Dapeng Li; Tan Chen; Yang Hu; Yu Zhou; Qingwei Liu; Dongming Zhou; Xia Jin; Zhong Huang
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.